SPARROW-QUANTUM
ORCA Computing, Pixel Photonics, Sparrow Quantum, and the Niels Bohr Institute (NBI) announce their collaboration on the Eurostars project 'SupremeQ.' This landmark initiative brings together quantum experts from the United Kingdom, Germany, and Denmark with a shared goal of accelerating the development and commercialization of photonic quantum computing technologies to deliver quantum advantage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313844049/en/
ORCA PT-1 computer in assembly room (Photo: Business Wire)
Supported by Eurostars, a European funding program dedicated to assisting R&D-performing SMEs in developing marketable innovative products, processes, and services, the SupremeQ project will harness world-leading expertise. It will draw upon single-photon sources from Sparrow Quantum and NBI, single-photon detectors from Pixel Photonics, and full-stack photonic quantum computing system architecture from ORCA Computing. By uniting efforts, the SupremeQ consortium aims to drive breakthrough innovation in photonic quantum computing, paving the way for quantum advantage.
According to a report by Fortune Business Insights, the quantum computing market is forecasted to reach $6.5 billion by 2030 with a CAGR of 32.1%1. With a broad range of potential application areas offering significant advantages over current classical computations. The SupremeQ project aims to address the needs of this growing market demand for quantum computing capabilities by addressing key challenges such as system engineering for scale, high acquisition, and operation costs, as well as the need for specialized expertise.
By pioneering solutions for photonic quantum computing, the project aims to unveil groundbreaking innovations in performance, packaging, and system integration. Sparrow Quantum’s single-photon sources and Pixel Photonics detectors will be engineered to co-exist within a single cryostat, marking a breakthrough in quantum computing infrastructure. With reduced complexity and enhanced component proximity, this crucial milestone heralds the path to multiplying qubits while offering considerable manufacturability and cost advantages.
ORCA Computing will draw upon its deep knowledge in quantum photonic system architecture. This expertise will be used to integrate these developments and demonstrate state-of-the-art photon processing efficiencies and reconfigurability within a standard data center rack.
These advancements are necessary for the commercialization of quantum computers to reach advantage over classical computing systems signifying a significant leap toward achieving universal fault-tolerant quantum computing.
As the quantum computing market continues to evolve, the consortium is confident that their innovative SupremeQ solutions will generate considerable interest, driving diverse applications and accelerating the widespread adoption of quantum technologies across industries well beyond the conclusion of the Eurostars program.
Consortium partners share their perspectives on the groundbreaking developments of the project:
"I envision SupremeQ as a symphony of quantum brilliance, with each partner playing a unique instrument,” stated Dr. Kurt Stokbro, CEO of Sparrow Quantum. “Together, we're composing a masterpiece that I believe will make some noise around the world."
"The advancements made possible through the SupremeQ project represent a significant leap forward in quantum computing technology," stated Nicolai Walter, CEO of Pixel Photonics. "By combining cutting-edge components and innovative architecture, we will be well-positioned to redefine the boundaries of what is possible in quantum computing."
"We are delighted to announce this new partnership with two other leading European firms,” affirmed Richard Murray, CEO of ORCA Computing. "With its unparalleled performance, the outcome of this project will spearhead new frontiers in hybrid quantum-classical computation, driving significant advancements in machine learning and optimization."
“We are thrilled to collaborate with esteemed industry partners on the SupremeQ project, which represents a significant step forward in quantum computing innovation," says Peter Lodahl, Professor at the Niels Bohr Institute.
Explore the SupremeQ project and how it will revolutionize the industry by contacting the consortium partners for more information.
Source 1: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/quantum-computing-market-104855
About ORCA Computing:
ORCA Computing, headquartered in London, UK with offices in the United States and Canada, is a leading developer and provider of full-stack photonic quantum computing systems. Established in 2019 and originating from the University of Oxford, the company provides an innovative approach to photonic quantum computing. Anchored in a modular optical fiber-based architecture, ORCA’s proprietary methods of manipulating the time, frequency and switching of single photons paves the way for quantum computing using significantly fewer components. ORCA Computing has successfully delivered numerous on-premises quantum computers to leading customers including the UK Ministry of Defence and the Poznan Supercomputing and Networking Center.
For more information, please visit www.orcacomputing.com.
About Pixel Photonics:
Pixel Photonics is a German deep-tech startup that has developed a unique approach to integrate SNSPDs (Superconducting Nanowire Single Photon Detectors) on a chip waveguide. Pixel Photonics combines the superior features of SNSPDs with the versatility of an integrated photonic platform to provide highly parallelized, efficient and ultra-fast single-photon detection. Waveguide integration enables the use of SNSPDs for photon counting, paving the way for high-performance and scalable photonic quantum computing. The Pixel Photonics team consists of 36 employees from 8 different countries.
Learn more about Pixel Photonics and the WI-SNSPD technology at www.pixelphotonics.com.
About Sparrow Quantum:
Sparrow Quantum, headquartered in Copenhagen, Denmark, is a leading provider of single-photon components enabling the photonic quantum revolution. Our flagship product, a deterministic single-photon source, sets industry standards and earns acclaim from leading quantum technology groups worldwide. With roots in over two decades of pioneering research at the Niels Bohr Institute, our technology seamlessly integrates with leading photonic quantum computing platforms and communication systems. Our dedication to advancing light-matter interfaces for quantum technologies ensures we deliver essential components for scaling up advanced quantum technology applications in information processing and communication.
Discover more about Sparrow Quantum at www.sparrowquantum.com.
About the Niels Bohr Institute, Copenhagen University:
At the Niels Bohr Institute, University of Copenhagen, we research and teach in a broad spectrum of physics areas: quantum computers and communication, astrophysics, particle physics, computational physics, solid state physics, climate and geophysics, and biophysics. In the past decade, our research in solid-state physics and quantum optics has continuously intensified with several new, large research centres. Among the latest is the Copenhagen Center for Biomedical Quantum Sensing, which will research in the development of ultra-sensitive sensors for the early detection of diseases. Last year, the Novo Nordisk Foundation Quantum Computing Program was also inaugurated, the goal of which is to develop a fully functional quantum computer within the next 12 years.
For more information, please visit www.nbi.ku.dk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240313844049/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Overture Life Launches European Preorder Waitlist for DaVitri, the World’s First Microfluidics-Based Automated Vitrification Platform17.9.2025 07:00:00 CEST | Press release
Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world’s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) facilities will be among the first in Europe to harness DaVitri to reduce manual workloads for their embryologists while eliminating operator variability, thereby providing patients with faster, more consistent procedures. As infertility rates spike worldwide, interest in egg freezing continues to rise while the infrastructure to support it lags behind. Egg freezing requires vitrification, typically a time-intensive, manual process vulnerable to human error that can only be performed by extensively trained embryologists. This has resulted in variability in egg and embryo survival rates that directly impa
Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 202517.9.2025 07:00:00 CEST | Press release
Across both STOP-HS1 and STOP-HS2, povorcitinib treatment resulted in continued clinically meaningful and statistically significant improvements for patients with active moderate to severe hidradenitis suppurativa (HS) through Week 24At Week 24, nearly 60% of efficacy-evaluable patients among both povorcitinib treatment groups achieved HiSCR50Additionally, patients treated with povorcitinib achieved HiSCR75 (31.0%-40.3%), HiSCR90 (13.8%-27.7%) and HiSCR100 (9.2%-21.3%) through Week 24Povorcitinib-treated patients also achieved greater improvements in skin pain by the first visit (Week 3) through Week 24 with 62%-70% achieving mild or no pain at Week 24 Incyte (Nasdaq:INCY) today announced new 24-week interim data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). These data will
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin17.9.2025 07:00:00 CEST | Press release
Results from a real-world clinical study conducted in China, to be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress, reveal that modern lifestyles and environmental triggers significantly impact individuals with sensitive skin1 Data show that people with sensitive skin living in modern environments have higher levels of inflammation compared to those living traditional, less stressful lifestyles1 This first-of-its-kind study was conducted by Galderma’s Global Sensitive Skincare Faculty (GSSF) as part of the company’s commitment to transforming the understanding and care of sensitive skin1 Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental factors on individuals with sensitive skin.1 Results from the study, conducted by dermatology experts from Galderma’s Global Sensitive Skincare Faculty (GSSF), will be pres
Ant International Recognized as an Inaugural Foreign Institution Partner by China’s Cross-Border Interconnection Payment Gateway17.9.2025 06:24:00 CEST | Press release
Expanded direct connection enables Alipay+ to help global wallets build China merchant networkAnt is the largest player in the CPG scheme in terms of coverage, use cases and business volume Ant International is appointed as an inaugural foreign Institution Partner (FIP) of China’s Cross-border Interconnection Payment Gateway (CPG), under the guidance of the People’s Bank of China and the Payment & Clearing Association of China (PCAC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916704996/en/ Eric Jing, Chairman of Ant Group and Ant International, and Cyril Han, CEO of Ant Group, celebrating China's Top International consumer destinations with card and wallet partners. Ant International and Alipay are the largest player in the CPG scheme with the largest number of card network and wallet partners, the broadest use cases and largest business volume. The new CPG scheme is designed to raise connection efficiency and improv
Ant International Joins Google's Agent Payments Protocol as a Launch Partner17.9.2025 06:00:00 CEST | Press release
Co-building a trusted foundation for agentic commerce Ant International, a leading global provider of digital payments, digitisation, and financial technology, today announced its role as a launch partner of Google to develop Agent Payments Protocol (AP2), an open rulebook that defines how AI agents can reliably transact with the authorisation of users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916339888/en/ With the rise of agentic commerce, AI agents will increasingly transact on behalf of users for services, products, and even other agents. Existing payment systems are built around direct human interaction and cannot currently address the new requirements of authorization, verification, and interoperability among agents. To address this gap, Google has collaborated with the industry to introduce AP2. AP2 defines the key components of agentic payments and provides a protocol to ensure user intent is verifiable, tra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom